Design Therapeutics, Inc. (DSGN): Price and Financial Metrics
DSGN Price/Volume Stats
| Current price | $5.48 | 52-week high | $7.77 |
| Prev. close | $5.48 | 52-week low | $2.13 |
| Day low | $5.34 | Volume | 72,100 |
| Day high | $5.51 | Avg. volume | 240,119 |
| 50-day MA | $5.53 | Dividend yield | N/A |
| 200-day MA | $4.26 | Market Cap | 310.28M |
DSGN Stock Price Chart Interactive Chart >
Design Therapeutics, Inc. (DSGN) Company Bio
Design Therapeutics, Inc. develops therapies for the treatment of degenerative disorders caused by nucleotide repeat expansions. The company engages in the development of a program for the treatment of Friedreich's ataxia and degenerative diseases such as Fragile X syndrome and myotonic dystrophy. The company was incorporated in 2017 and is based in Carlsbad, California.
DSGN Price Returns
| 1-mo | -3.35% |
| 3-mo | 12.07% |
| 6-mo | 25.69% |
| 1-year | 147.96% |
| 3-year | -73.02% |
| 5-year | N/A |
| YTD | 106.79% |
| 2023 | -74.17% |
| 2022 | -52.08% |
| 2021 | N/A |
| 2020 | N/A |
| 2019 | N/A |
Loading social stream, please wait...